Collaboration and Financing: New Partnership Models to Address Tuberculosis
DescriptionThe economic burden of tuberculosis on governments and businesses in affected countries has been estimated in the range of billions of dollars per year. From prevention to treatment, the direct and indirect costs of the disease are staggering and will plague emerging and frontier markets for decades through lost productivity and health care expenditures. Traditional sources of funding from governments and donors are inadequate to support all of the necessary interventions. New industry stakeholders must be engaged and new financing models must be developed to scale up resources from industry, investors and donors.
With a goal of promoting wider implementation among key stakeholders, this session will bring together a small group of industry leaders, donors and global health experts to review financing mechanisms, from a social impact bond to risk mitigation tools that support new investment funds. These models could provide funding at various stages of the product development value chain, ensuring that both prevention and treatment are better capitalized to make a significant impact. The session will provide an opportunity to map out next steps toward increased adoption of the relevant models.